In the latest trading session,, 1.23 million Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.63. With the company’s most recent per share price at $12.00 changed hands at -$0.36 or -2.94% at last look, the market valuation stands at $3.35B. IOVA’s current price is a discount, trading about -52.75% off its 52-week high of $18.33. The share price had its 52-week low at $3.21, which suggests the last value was 73.25% up since then. When we look at Iovance Biotherapeutics Inc’s average trading volume, we note the 3-month average coming to 9.28 million.

Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information

Instantly IOVA was in red as seen in intraday trades today. With action -8.22%, the performance over the past five days has been red. The drop to weekly highs of 13.30 subtracted -2.94% to the stock’s daily price. The company’s shares are showing year-to-date upside of 47.55%, with the 5-day performance at -8.22% in the red. However, in the 30-day time frame, Iovance Biotherapeutics Inc (NASDAQ:IOVA) is -15.58% down. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Iovance Biotherapeutics Inc (IOVA) estimates and forecasts

Data shows that the Iovance Biotherapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 230.47% over the past 6 months, a 25.93% in annual growth rate that is considerably higher than the industry average of 13.00%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.25%. The 2024 estimates are for Iovance Biotherapeutics Inc earnings to increase by 30.65%.